STME — Stimcell Energetics Inc.

OTC · Health Care · Health Care Equipment & Supplies · CIK 1493712 ·
Last close
$0.29
Market Cap
$6.13M
52W High
$0.43
52W Low
$0.28
ADV30
3,908
Next earnings
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 0 -102,054 -90,566 34,521 10,257 1,712,941
Nov 2025 0 -271,498 -309,748 52,345 46,159 1,594,639
May 2025 0 -261,646 -219,329 21,222 14,581 1,267,508
Feb 2025 0 -89,534 -140,537 17,110 6,678 1,087,325

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-262,592
Investing CF
Financing CF
$247,106
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.03
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-11,527,472
Inventory
Receivables
$23
ST Investments
EBIT TTM
$-704,226
Pretax Income TTM
$-760,180
Interest Exp TTM
$55,954
Analysts

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
May 2025 0 -504,949 -566,293 21,222 1,267,508 -141,600
May 2024 0 -261,270 -142,486 46,122 872,577 -145,898
May 2023 2,762 -447,658 -495,042 103,270 2,488,750 -272,209
May 2022 6,065 -671,693 -697,379 41,344 2,050,375 -450,591
May 2021

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-139,508
OpCashFlow TTM
$0
Assets (Latest)
$21,222
Forward EPS
$-0.02

Peers — same industry

TickerNameMarket CapLastDaily %
HSCS HeartSciences Inc. $6.15M $1.93
RBOT Vicarious Surgical Inc. $6.21M $0.96
CLGN CollPlant Biotechnologies Ltd $5.98M $0.41
MHUAF Meihua International Medical Technologies Co., Ltd. $6.33M $7.40
INBS INTELLIGENT BIO SOLUTIONS INC. $6.34M $2.65

News headlines (Yahoo Finance, 1h cache)

Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
2026-05-15 16:22 · Yahoo
StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach
2026-03-19 13:15 · Yahoo
StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function
2025-12-02 14:15 · Yahoo
StimCell Energetics Inc. Successfully Uplists to OTCQB Market
2025-10-24 19:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.